News
News
- Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting
06:01 - GlobeNewswire - Stifel Financial Corp. Completes Acquisition of the Capital Markets Business of GMP Capital Inc.
12/06/2019 / 23:45 - GlobeNewswire - Nokia Bell Labs Prize awarded to new processor technology pioneered by student and professor team from University of California at Berkeley
12/06/2019 / 22:31 - GlobeNewswire - Ft. Lauderdale Leaders Come Together to help Raise Funding for HBCUs and Area Students at the 19th Annual UNCF Leader’s Luncheon
12/06/2019 / 21:57 - GlobeNewswire - BRITELY DENTURES + IMPLANTS STUDIO SELECTS THE PHOENIX METRO AREA FOR FIRST LOCATION.
12/06/2019 / 21:42 - GlobeNewswire - Dr. Lenore Bacek of BluePearl Selected to Serve as Vice President of ACVECC
12/06/2019 / 18:50 - GlobeNewswire - EANS-Adhoc: ams AG / ams announces acceptance threshold for ams’ takeover offer for OSRAM is satisfied EAE
12/06/2019 / 17:40 - euro adhoc - European stocks close in green after data
12/06/2019 / 17:30 - TeleTrader - Zecotek Suspended from Trading on the TSX Venture Exchange
12/06/2019 / 15:00 - Newsfile Corp - Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting
12/06/2019 / 14:45 - GlobeNewswire
Real-time